Tamar Thompson

Insider Reports History

Location
La Jolla, CA
Signature
/s/ John B. Moriarty, Jr., J.D., Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Tamar Thompson:

Company Role Class Num Shares Value Price $ Report Date Ownership
CATALYST PHARMACEUTICALS, INC. Director Restricted Stock Units 119,663 $394,744 $4.01 08 Dec 2025 Direct
CATALYST PHARMACEUTICALS, INC. Director Common Stock, par value $0.001 per share 3,773 $80,855 $21.43 08 Dec 2025 Direct
Avidity Biosciences, Inc. Director Common Stock 0 $0 $72.51 27 Feb 2026 Direct
CATALYST PHARMACEUTICALS, INC. Director Options to purchase common stock 116,555 20 Nov 2025 Direct
Avidity Biosciences, Inc. Director Stock Option (Right to Buy) 0 27 Feb 2026 Direct

Insider Reports Filed by Tamar Thompson

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RNA Avidity Biosciences, Inc. 27 Feb 2026 5 $0 4 Director 27 Feb 2026, 15:26
CPRX CATALYST PHARMACEUTICALS, INC. 08 Dec 2025 2 $0 4 Director 10 Dec 2025, 17:00
CPRX CATALYST PHARMACEUTICALS, INC. 20 Nov 2025 4 $0 4 Director 24 Nov 2025, 20:08
RNA Avidity Biosciences, Inc. 10 Jun 2025 2 $0 4 Director 12 Jun 2025, 18:24
CPRX CATALYST PHARMACEUTICALS, INC. 09 Dec 2024 2 $0 4 Director 11 Dec 2024, 17:00
CPRX CATALYST PHARMACEUTICALS, INC. 21 Nov 2024 2 $0 4 Director 25 Nov 2024, 17:00
RNA Avidity Biosciences, Inc. 07 Oct 2024 3 -$520,359 4 Director 09 Oct 2024, 17:23
RNA Avidity Biosciences, Inc. 13 Jun 2024 1 $0 4 Director 14 Jun 2024, 18:56
CPRX CATALYST PHARMACEUTICALS, INC. 08 Dec 2023 2 $0 4 Director 12 Dec 2023, 17:00
RNA Avidity Biosciences, Inc. 15 Jun 2023 1 $0 4 Director 20 Jun 2023, 16:02
CPRX CATALYST PHARMACEUTICALS, INC. 25 May 2023 0 $0 3 Director 05 Jun 2023, 17:00
RNA Avidity Biosciences, Inc. 15 Jun 2022 1 $0 4 Director 17 Jun 2022, 20:55